Impact of Persistent Multidrug-Resistant Gram-Negative Bacteremia on Clinical Outcome and Mortality

Shiori Kitaya1,2, Hajime Kanamori1, Yukio Katori2

  • 1Department of Infectious Diseases, Internal Medicine, Tohoku University Graduate School of Medicine, Sendai 980-8574, Japan.

Insights

Persistent bacteremia (PB) from multidrug-resistant Enterobacterales significantly increases mortality. Clearing PB through follow-up blood cultures is crucial for improving survival rates in gram-negative rod infections.

Area of Science:

  • Infectious Diseases
  • Clinical Microbiology
  • Antimicrobial Resistance

Background:

  • Persistent bacteremia (PB) caused by gram-negative rods (GNRs) presents challenges regarding antimicrobial resistance (AMR) and clearance.
  • Understanding the clinical impact of AMR and PB clearance is essential for patient outcomes.

Purpose of the Study:

  • To investigate differences in PB caused by Enterobacterales and non-fermentative GNRs (NF-GNRs).
  • To analyze the impact of AMR and PB clearance status on mortality.

Main Methods:

  • Secondary analysis of a retrospective cohort study at Tohoku University Hospital (2012-2021).
  • PB cases were categorized by AMR and clearance status.
  • Mortality rates were compared between bacterial groups and resistance/clearance statuses.

Main Results:

  • Late mortality was significantly higher in multidrug-resistant (MDR) Enterobacterales PB compared to non-MDR.
  • No significant mortality difference was observed for NF-GNRs with or without AMR.
  • Mortality rates were higher in the non-PB-clearance group for both Enterobacterales and NF-GNRs.

Conclusions:

  • MDR Enterobacterales PB requires careful management due to increased mortality risk.
  • Confirming PB clearance via follow-up blood cultures is vital for improving patient survival rates.

Related Concept Videos

Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
26
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
59
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
107
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
411
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
328